Gefticip 250mg

Buy Gefticip 250mg

Gefticip 250mg Tablet is used for Non-small cell lung cancer after failure of platinum and docetaxel chemotherapies, Treatment of metastatic non-small cell lung cancer in tumors with epidermal growth factor receptor exon 19 deletions or exon 21 substitution mutations and other conditions. Gefticip 250mg Tablet may also be used for purposes not listed in this medication guide.

Gefticip 250mg Tablet contains Gefitinib as an active ingredient.

Gefticip 250mg Tablet works by blocking signalling of epidermal growth factor receptor dependent proliferation.

Cipla manufactures Gefticip 250mg Tablet.

Composition

• Gefitinib

Company Name

• Cipla Ltd

How To Work

Gefticip 250mg Tablet is an anti-cancer medication. It works by blocking the action of the abnormal protein that signals cancer cells to multiply. This helps to stop or slow the spread of cancer cells.

What Is Gefticip 250mg

Gefticip 250mg Tablet is an anticancer medicine which is used in the treatment of cancer of the lungs. It should only be used under the supervision of a qualified physician. This medicine is not recommended for use in patients with lung and liver diseases.

How To Take

Take this medicine in the dose and duration as advised by your doctor. Swallow it as a whole. Do not chew, crush or break it. Gefticip 250 mg Tablet may be taken with or without food, but it is better to take it at a fixed time.

Gefticip 250 mg

Gefticip 250mg Tablet belongs to the class of chemotherapeutic drugs called signal transduction inhibitors. The drug acts by inhibiting or blocking the action of tyrosine kinases associated with epidermal growth factor receptor (EGFR). Thus, the drug prevents the proliferation and spread of the cancer cells.

Instructions

Take Gefticip 250mg Tablet as instructed by the doctor. Do not consume larger quantities than prescribed. It should be used as prescribed by the doctor to prevent the spread of cancer to other parts of the body. Discontinue the treatment if any symptoms of allergic skin reactions appear.

Drug Interactions

• Antacids
• Histamine H2-receptor antagonists
• Itraconazole
• Ketoconazole
• Phenytoin
• Proton pump inhibitors
• Rifampicin
• Tricyclic antidepressant
• Warfarin

Side Effects

• Skin reactions
• Nail disorders
• Diarrhea
• Vomiting
• Nausea
• Stomatitis
• Decreased appetite
• Conjunctivitis
• Blepharitis
• Dry eye

Warning

Pregnancy – This medicine is not recommended for use in pregnant women.

Breast-feeding – This medicine is not recommended for use in breastfeeding women unless absolutely necessary. If this medicine is prescribed, your doctor will advise you to discontinue breastfeeding.

Skin reactions – Patients receiving Gefticip 250 mg Tablet have experienced severe skin reactions like toxic epidermal necrolysis, Stevens Johnson syndrome, and erythema multiforme. Close monitoring of symptoms like change in color of the skin, skin rashes, itching, blistering, etc. is necessary while receiving this medicine. Any such symptoms should be reported to the doctor on priority. The treatment should be discontinued if these symptoms appear.

Precaution

Avoid concomitant use of this drug with proton pump inhibitors

Contact doctor for new onset or worsening of pulmonary symptoms such as dyspnea, cough and fever

Contact doctor for severe or persistent diarrhea

Contact doctor if developping eye symptoms, lacrimation, light sensitivity, blurred vision, eye pain, red eye, or changes in vision

Discontinue breast-feeding during treatment with this drug

If treatment with a proton-pump inhibitor is required, take this drug 12 hours after the last dose or 12 hours before the next dose of the proton-pump inhibitor

Monitor your liver function

Patients taking warfarin should be monitored regularly for changes in prothrombin time or international normalized ratio

Report any new symptoms indicating hepatic toxicity

Risk of bullous and exfoliative skin disorders

Dosage

• Gefticip 250mg

Uses

Gefticip 250mg Tablet is used for the treatment, control, prevention, & improvement of the following diseases, conditions and symptoms:

• Non-small cell lung cancer after failure of platinum and docetaxel chemotherapies
• Treatment of metastatic non-small cell lung cancer in tumors with epidermal growth factor receptor exon 19 deletions or exon 21 substitution mutations

Storage

Store in a cool, dry place away from the reach of children. – Medicines must not be used past the expiry date.

Review

“I had excellent customer service I would recommend gefticip 250mg from strapcart.com them to my friends.” – Lisbeth Major